This study tested a new eye drop called IRX-101 to see if it could make eye injections less painful and reduce damage to the eye's surface. 155 adults with retinal disease who were already getting regular eye injections took part. The goal was to compare IRX-101 to the standard c…
Phase: PHASE2 • Sponsor: iRenix Medical, Inc. • Aim: Symptom relief
Last updated Apr 26, 2026 20:01 UTC